6 not yet recruiting, 4 recruiting, 1 withdrawn. 11 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Not yet recruiting 6, Recruiting 4, Withdrawn 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow PTSD - Post Traumatic Stress Disorder: new trials by email Literature Review of PTSD - Post Traumatic Stress Disorder trials Research Report on PTSD - Post Traumatic Stress Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Written Exposure Therapy Plus Adjunctive Methylphenidate Treatment for Veterans With PTSD Written Exposure Therapy (WET), methylphenidate (MPH), placebo (PBO) - PTSD - Post Traumatic Stress Disorder | Phase 2 | Not yet recruiting | VA Office of Research and Development | 138 | 2027-07-01 | 2026-10-29 |
| Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies Transcranial Magnetic Stimulation, Psilocybin (drug), Neurofeedback - PTSD, PTSD - Post Traumatic Stress Disorder | Phase 2 | Not yet recruiting | University of New Mexico | 150 | 2026-12-31 | 2026-10-30 |
| ONE-P TMS Military Veterans D-Cycloserine (DCS), Placebo, Intermittent Theta Burst Stimulation (iTBS) - PTSD - Post Traumatic Stress Disorder | Phase 2 | Not yet recruiting | Fidel Vila-Rodriguez, MD, PhD, FRCPC, DFAPA | 50 | 2026-11-01 | 2026-08-20 |
| ONE-P TMS First Responders D-Cycloserine (DCS), Placebo, Intermittent Theta Burst Stimulation (iTBS) - PTSD - Post Traumatic Stress Disorder | Phase 2 | Not yet recruiting | Fidel Vila-Rodriguez, MD, PhD, FRCPC, DFAPA | 50 | 2026-11-01 | 2026-08-19 |
| Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder COMP360 psilocybin - PTSD - Post Traumatic Stress Disorder, PTSD | Phase 2 / Phase 3 | Recruiting | COMPASS Pathways | 300 | 2026-09-14 | 2026-11-05 |
| HBOT Effects on First Responders' Cognition and Well-Being Hyperbaric Oxygen Therapy (HBOT) - Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder | Phase 2 | Recruiting | Summit Hyperbarics and Wellness | 54 | 2026-09-11 | 2026-10-01 |
| Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence Propranolol, 120mg, Placebo - PTSD - Post Traumatic Stress Disorder | Phase 2 | Not yet recruiting | University Hospital, Tours | 34 | 2026-09-01 | 2026-03-05 |
| Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans PT150, Placebo - PTSD - Post Traumatic Stress Disorder | Phase 2 | Not yet recruiting | San Diego Veterans Healthcare System | 120 | 2026-04-01 | 2025-12-23 |
| Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy Hyperbaric Oxygen Therapy - TBI Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder | Phase 2 | Recruiting | Summit Hyperbarics and Wellness | 54 | 2025-10-01 | 2025-10-09 |
| Trifecta Research Study Hormone Replacement Therapy (HRT), Magnetic Resonance Therapy (MeRT), ibogaine with magnesium treatment - PTSD - Post Traumatic Stress Disorder, Cognitive Dysfunction | Phase 2 | Withdrawn | Johns Hopkins University | 2025-09-01 | 2025-08-22 | |
| Neuromodulation of the Hippocampus to Reduce Intrusive Re-Experiencing in PTSD: A Randomized Controlled Trial Hippocampal stimulation using repetitive transcranial magnetic stimulation (rTMS), Sham stimulation using repetitive transcranial magnetic stimulation (rTMS) - PTSD - Post Traumatic Stress Disorder, Intrusive Memories of Traumatic Event(s) | Phase 2 | Recruiting | Tel Aviv University | 60 | 2024-11-01 | 2024-11-01 |
Combat Disorders (11) · Stress Disorders, Post-Traumatic (8) · Brain Injuries, Traumatic (3) · Post-Concussion Syndrome (2) · Wounds and Injuries (2) · Anxiety Disorders (1) · Brain Injuries (1) · Cognitive Dysfunction (1) · Depression (1) · Depressive Disorder, Major (1) · Suicidal Ideation (1)
Mental Disorders (11) · Stress Disorders, Traumatic (11) · Trauma and Stressor Related Disorders (11) · Brain Diseases (3) · Central Nervous System Diseases (3) · Craniocerebral Trauma (3) · Nervous System Diseases (3) · Trauma, Nervous System (3) · Wounds and Injuries (3) · Behavior (2) · Behavioral Symptoms (2) · Brain Concussion (2) · Brain Injuries (2) · Head Injuries, Closed (2) · Wounds, Nonpenetrating (2)
Cycloserine (2) · Hyperbaric Oxygenation (2) · Transcranial Magnetic Stimulation (2) · (11R,13S,17S)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta(a)phenanthren-3-one (1) · Hormone Replacement Therapy (1) · Ibogaine (1) · Methoxydimethyltryptamines (1) · Methylphenidate (1) · Neurofeedback (1) · Pharmaceutical Preparations (1) · Propranolol (1) · Psilocybin (1)
Fidel Vila-Rodriguez, MD, PhD, FRCPC, DFAPA (2) · Summit Hyperbarics and Wellness (2) · COMPASS Pathways (1) · Johns Hopkins University (1) · San Diego Veterans Healthcare System (1) · Tel Aviv University (1) · University Hospital, Tours (1) · University of New Mexico (1) · VA Office of Research and Development (1)
United States (6) · Canada (3) · Israel (1)
Fidel Vila-Rodriguez, M.D., PhD, FRCPC, DFAPA (2) · Andrea Townsend, PhD (1) · Davin Quinn, MD (1) · Sandeep Nayak, MD (1) · Steve Wyman, MD (1) · Steven Wyman, MD (1) · Victoria B Risbrough (1) · Victoria Risbrough, PhD (1) · Yair Bar-Haim, PhD (1)
2023 (1)